Murray Hill – Managing Director & CEO – Elevate Uranium (ASX:EL8) is a uranium exploration company that has significant resources in Namibia and Australia and is making new discoveries through active exploration programs.
Copyright 2024 – Finance News Network
Source: Finance News Network
10 Jul 2023 - INOVIQ Limited (ASX:IIQ) CEO Dr Leearne Hinch discusses recent news, including excellent sensitivity and specificity results for the company's SubB2M breast cancer test.
Read More16 Apr 2025 - Managing Director Jarrad Haynes shares how the firm is navigating risk, scaling development, and positioning for long-term growth.
Read More15 Aug 2024 - Forbidden Foods Limited (ASX:FFF) CEO and Managing Director Alex Aleksic provides an introduction to the company, discussing its recent acquisition of Good Oats.
Read More30 Jul 2024 - Justin Virgin - Executive Director - Terrain Minerals (ASX:TMX) is a West Australian based minerals exploration company focused on the world class mineral provinces in Western Australia. Terrain is actively looking for opportunities within other states of Australia and internationally.
Read More7 July 2020 - Renergen (ASX:RLT) Managing Director, Stefano Marani talks about its high concentration of helium from Phase 1 drill results at its Virginia Gas Field in the Karoo Basin, South Africa.
Read More06 Apr 2020 - Cyclopharm (ASX:CYC) CEO & Managing Director, James McBrayer talks about its new drug application with the US FDA for Technegas and applications beyond pulmonary embolism in chronic chronic obstructive pulmonary ( COPD ) and asthma.
Read More11 Aug 2025 - Inside Etherstack’s multi-year partnership with the world’s largest telecom
Read More07 Sep 2023 - Empire Energy Group (ASX:EEG) CEO Alex Underwood discusses large scale future well drilling projects, and anticipates commercial production by 2025.
Read More01 Jul 2022 - Shaw and Partners Chief Investment Officer Martin Crabb discusses market outlook and which sectors and stocks do well in a downturn.
Read More26 Aug 2021 - Chimeric Therapeutics Limited (ASX:CHM) Chief Operating Officer Jennifer Chow talks about the company's licensing of a novel, third-generation CDH17 CAR T cell therapy from the University of Pennsylvania, its recent FDA IND clearance and plans for ongoing growth.
Read More
